DUS3L_HUMAN - dbPTM
DUS3L_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DUS3L_HUMAN
UniProt AC Q96G46
Protein Name tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like
Gene Name DUS3L
Organism Homo sapiens (Human).
Sequence Length 650
Subcellular Localization
Protein Description Catalyzes the synthesis of dihydrouridine, a modified base found in the D-loop of most tRNAs..
Protein Sequence MAEGTAEAPLENGGGGDSGAGALERGVAPIKRQYLTTKEQFHQFLEAKGQEKTCRETEVGDPAGNELAEPEAKRIRLEDGQTADGQTEEAAEPGEQLQTQKRARGQNKGRPHVKPTNYDKNRLCPSLIQESAAKCFFGDRCRFLHDVGRYLETKPADLGPRCVLFETFGRCPYGVTCRFAGAHLRPEGQNLVQEELAARGTQPPSIRNGLDKALQQQLRKREVRFERAEQALRRFSQGPTPAAAVPEGTAAEGAPRQENCGAQQVPAGPGTSTPPSSPVRTCGPLTDEDVVRLRPCEKKRLDIRGKLYLAPLTTCGNLPFRRICKRFGADVTCGEMAVCTNLLQGQMSEWALLKRHQCEDIFGVQLEGAFPDTMTKCAELLSRTVEVDFVDINVGCPIDLVYKKGGGCALMNRSTKFQQIVRGMNQVLDVPLTVKIRTGVQERVNLAHRLLPELRDWGVALVTLHGRSREQRYTKLADWQYIEECVQAASPMPLFGNGDILSFEDANRAMQTGVTGIMIARGALLKPWLFTEIKEQRHWDISSSERLDILRDFTNYGLEHWGSDTQGVEKTRRFLLEWLSFLCRYVPVGLLERLPQRINERPPYYLGRDYLETLMASQKAADWIRISEMLLGPVPPSFAFLPKHKANAYK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAEGTAEAP
------CCCCCCCCC
24.7522814378
31AcetylationERGVAPIKRQYLTTK
HCCCCCCCCCCCCCH
32.1825953088
34PhosphorylationVAPIKRQYLTTKEQF
CCCCCCCCCCCHHHH
15.2829759185
36PhosphorylationPIKRQYLTTKEQFHQ
CCCCCCCCCHHHHHH
30.7829759185
37PhosphorylationIKRQYLTTKEQFHQF
CCCCCCCCHHHHHHH
29.9529759185
38UbiquitinationKRQYLTTKEQFHQFL
CCCCCCCHHHHHHHH
44.26-
48AcetylationFHQFLEAKGQEKTCR
HHHHHHHCCCCCCCC
52.327677919
48UbiquitinationFHQFLEAKGQEKTCR
HHHHHHHCCCCCCCC
52.32-
73AcetylationELAEPEAKRIRLEDG
CCCCCCCCEEECCCC
46.8523954790
73UbiquitinationELAEPEAKRIRLEDG
CCCCCCCCEEECCCC
46.8521906983
73 (in isoform 2)Ubiquitination-46.8521890473
73 (in isoform 1)Ubiquitination-46.8521890473
101AcetylationGEQLQTQKRARGQNK
CHHHHHHHHHCCCCC
51.9526051181
101UbiquitinationGEQLQTQKRARGQNK
CHHHHHHHHHCCCCC
51.9521906983
101 (in isoform 1)Ubiquitination-51.9521890473
101 (in isoform 2)Ubiquitination-51.9521890473
114UbiquitinationNKGRPHVKPTNYDKN
CCCCCCCCCCCCCCC
42.99-
120UbiquitinationVKPTNYDKNRLCPSL
CCCCCCCCCCCCHHH
33.34-
134UbiquitinationLIQESAAKCFFGDRC
HHHHHHHHHHHCCHH
31.15-
154 (in isoform 2)Ubiquitination-28.9121890473
154 (in isoform 1)Ubiquitination-28.9121890473
154UbiquitinationVGRYLETKPADLGPR
HHHHHCCCCCCCCCC
28.9121906983
174 (in isoform 3)Ubiquitination-8.0621890473
193 (in isoform 3)Ubiquitination-41.4321890473
212UbiquitinationSIRNGLDKALQQQLR
HHHCHHHHHHHHHHH
56.91-
212AcetylationSIRNGLDKALQQQLR
HHHCHHHHHHHHHHH
56.9125953088
236PhosphorylationEQALRRFSQGPTPAA
HHHHHHHHCCCCCCC
32.2025159151
240PhosphorylationRRFSQGPTPAAAVPE
HHHHCCCCCCCCCCC
32.1721712546
249PhosphorylationAAAVPEGTAAEGAPR
CCCCCCCCCCCCCCC
22.4920068231
271PhosphorylationQVPAGPGTSTPPSSP
CCCCCCCCCCCCCCC
32.3429255136
272PhosphorylationVPAGPGTSTPPSSPV
CCCCCCCCCCCCCCC
44.8529255136
273PhosphorylationPAGPGTSTPPSSPVR
CCCCCCCCCCCCCCC
38.7729255136
276PhosphorylationPGTSTPPSSPVRTCG
CCCCCCCCCCCCCCC
48.7729255136
277PhosphorylationGTSTPPSSPVRTCGP
CCCCCCCCCCCCCCC
32.9429255136
281PhosphorylationPPSSPVRTCGPLTDE
CCCCCCCCCCCCCCH
23.2730576142
284 (in isoform 3)Ubiquitination-33.9421890473
286PhosphorylationVRTCGPLTDEDVVRL
CCCCCCCCCHHHEEC
40.2421815630
306UbiquitinationKRLDIRGKLYLAPLT
CCCCCCCEEEEECCC
24.90-
308PhosphorylationLDIRGKLYLAPLTTC
CCCCCEEEEECCCCC
12.3322817900
354MethylationMSEWALLKRHQCEDI
CHHHHHHHHHCCCCC
49.00-
377 (in isoform 3)Ubiquitination-2.3321890473
382PhosphorylationTKCAELLSRTVEVDF
HHHHHHHHCCEEEEE
38.2324719451
403UbiquitinationCPIDLVYKKGGGCAL
CCEEEEEECCCCEEE
37.15-
404UbiquitinationPIDLVYKKGGGCALM
CEEEEEECCCCEEEC
45.13-
416UbiquitinationALMNRSTKFQQIVRG
EECCCCHHHHHHHHC
42.2821890473
416AcetylationALMNRSTKFQQIVRG
EECCCCHHHHHHHHC
42.2825953088
416SumoylationALMNRSTKFQQIVRG
EECCCCHHHHHHHHC
42.2828112733
416 (in isoform 2)Ubiquitination-42.2821890473
416 (in isoform 1)Ubiquitination-42.2821890473
435 (in isoform 1)Ubiquitination-22.6421890473
435UbiquitinationLDVPLTVKIRTGVQE
CCCCEEEEECCCHHH
22.6421890473
435 (in isoform 2)Ubiquitination-22.6421890473
526 (in isoform 1)Ubiquitination-34.6921890473
526UbiquitinationIARGALLKPWLFTEI
EECCHHHCHHHHHHH
34.6921890473
534UbiquitinationPWLFTEIKEQRHWDI
HHHHHHHHHHCCCCC
41.38-
542PhosphorylationEQRHWDISSSERLDI
HHCCCCCCHHHHHHH
25.91-
543PhosphorylationQRHWDISSSERLDIL
HCCCCCCHHHHHHHH
36.23-
544PhosphorylationRHWDISSSERLDILR
CCCCCCHHHHHHHHH
21.68-
580PhosphorylationRFLLEWLSFLCRYVP
HHHHHHHHHHHHHCC
19.7624719451
610PhosphorylationPYYLGRDYLETLMAS
CCCCCHHHHHHHHHH
12.70-
619 (in isoform 1)Ubiquitination-42.9421890473
619UbiquitinationETLMASQKAADWIRI
HHHHHHHHHHHHHHH
42.942190698
643UbiquitinationPSFAFLPKHKANAYK
CHHHCCHHHHCCCCC
60.94-
645UbiquitinationFAFLPKHKANAYK--
HHCCHHHHCCCCC--
49.84-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of DUS3L_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DUS3L_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DUS3L_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
BCAT1_HUMANBCAT1physical
22863883
CALU_HUMANCALUphysical
22863883
DPP9_HUMANDPP9physical
22863883
U5S1_HUMANEFTUD2physical
22863883
T2FA_HUMANGTF2F1physical
22863883
KAP1_HUMANPRKAR1Bphysical
22863883
RPR1B_HUMANRPRD1Bphysical
22863883
SYSC_HUMANSARSphysical
22863883
SC23A_HUMANSEC23Aphysical
22863883
GDN_HUMANSERPINE2physical
22863883
SNF8_HUMANSNF8physical
22863883
XPO5_HUMANXPO5physical
22863883
EIF2A_HUMANEIF2Aphysical
26344197
TRM6_HUMANTRMT6physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DUS3L_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-273; SER-276 AND SER-277, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-273; SER-276 AND SER-277, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236, AND MASSSPECTROMETRY.
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-273, AND MASSSPECTROMETRY.

TOP